Search research articles
Contact Us
Filters
Showing results (121-130 of 157) with videos related to
Page
of 16
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 21, 2003
In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists
B B Yao, D G Witte, T R Miller, et al.
Journal of Neuro-Oncology
|
May 20, 2018
Earliest radiological progression in glioblastoma by multidisciplinary consensus review
Roelant S Eijgelaar, Anna M E Bruynzeel, Frank J Lagerwaard, et al.
British Journal of Pharmacology
|
May 23, 2006
Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand
David G Witte, Betty Bei Yao, Thomas R Miller, et al.
Assay and Drug Development Technologies
|
July 3, 2008
A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands
Thomas R Miller, John L Baranowski, Brian R Estvander, et al.
Journal of Medicinal Chemistry
|
July 11, 2009
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships
Chen Zhao, Minghua Sun, Youssef L Bennani, et al.
European Journal of Pharmacology
|
November 4, 2008
Cloning and characterization of the monkey histamine H3 receptor isoforms
Marina I Strakhova, Gerard B Fox, Tracy L Carr, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 2, 2005
Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
T A Esbenshade, B B Yao, D G Witte, et al.
Clinical and Translational Radiation Oncology
|
January 7, 2025
Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer
Christian A M Jongen, Ben J M Heijmen, Wilco Schillemans, et al.
Neuropharmacology
|
December 1, 2005
Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor
B Bei Yao, D G Witte, T R Miller, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 1, 2004
Structure-activity relationships of A-331440: a new histamine-3 antagonist with anti-obesity properties
R Faghih, T A Esbenshade, K M Krueger, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 157) with videos related to
Sort By:
Page
of 16
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
May 21, 2003
In vitro pharmacological properties of two novel non-imidazole H3 receptor (H3R) antagonists
B B Yao, D G Witte, T R Miller, et al.
Journal of Neuro-Oncology
|
May 20, 2018
Earliest radiological progression in glioblastoma by multidisciplinary consensus review
Roelant S Eijgelaar, Anna M E Bruynzeel, Frank J Lagerwaard, et al.
British Journal of Pharmacology
|
May 23, 2006
Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand
David G Witte, Betty Bei Yao, Thomas R Miller, et al.
Assay and Drug Development Technologies
|
July 3, 2008
A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands
Thomas R Miller, John L Baranowski, Brian R Estvander, et al.
Journal of Medicinal Chemistry
|
July 11, 2009
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships
Chen Zhao, Minghua Sun, Youssef L Bennani, et al.
European Journal of Pharmacology
|
November 4, 2008
Cloning and characterization of the monkey histamine H3 receptor isoforms
Marina I Strakhova, Gerard B Fox, Tracy L Carr, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
June 2, 2005
Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
T A Esbenshade, B B Yao, D G Witte, et al.
Clinical and Translational Radiation Oncology
|
January 7, 2025
Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer
Christian A M Jongen, Ben J M Heijmen, Wilco Schillemans, et al.
Neuropharmacology
|
December 1, 2005
Use of an inverse agonist radioligand [3H]A-317920 reveals distinct pharmacological profiles of the rat histamine H3 receptor
B Bei Yao, D G Witte, T R Miller, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|
April 1, 2004
Structure-activity relationships of A-331440: a new histamine-3 antagonist with anti-obesity properties
R Faghih, T A Esbenshade, K M Krueger, et al.
Page
of 16